PaloDEx signs definitive agreement to join Gendex, DEXIS, ISI

Danaher Corporation has announced entering into a definitive agreement to acquire PaloDEx Holding Oy, a manufacturer of dental imaging products with revenues of more than $100 million that goes to market under the Instrumentarium Dental and SOREDEX brands.

The transaction is subject to regulatory approval and customary closing conditions.

Instrumentarium Dental and SOREDEX will join Gendex, DEXIS, ISI, KaVo, and
Pelton & Crane as part of Danaher's group of market-leading dental equipment
companies. Instrumentarium Dental and SOREDEX and their products have been highly regarded by dental professionals since their inception 45 years ago.

PaloDEx's product range includes 3D CBCT, Panoramic X-ray (including the OP200), PSP (including the Optime IO PSP) and other intraoral and extraoral X-ray imaging systems.

"We believe this acquisition will be a game-changer for both of our companies and we are excited about the opportunity to acquire two of the leading imaging brands," said Henk van Duijnhoven, group executive of Danaher's KaVo Group.

"Instrumentarium Dental and Soredex's excellent digital imaging products and technology will be a great fit with our existing Gendex, DEXIS and i-CAT business. PaloDEx has an experienced team and we look forward to working with Henrik Roos, President of PaloDEx, and his team as we continue to build the business," he added.

Roos , who will remain in his position, added: "I am thrilled to join Danaher's dental business. The combined business will create a unique opportunity to provide new and innovative technologies in digital dentistry with focus on diagnostics and treatment planning for general practitioners and specialists."

For more information, go to Danaher.

To read more about Danaher, go to Danaher.

To comment on this subject, go to PennWell Dental Community site.